INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹361 Cr | ₹27 Cr | ₹125 Cr | ₹-19 Cr | ₹-23 Cr |
What is the latest Cash Flow from Financing Activities ratio of INNOVA CAPTAB ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹361 Cr |
Mar2023 | ₹27 Cr |
Mar2022 | ₹125 Cr |
Mar2021 | ₹-19 Cr |
Mar2020 | ₹-23 Cr |
How is Cash Flow from Financing Activities of INNOVA CAPTAB Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹361 Cr | 1,231.88 | |
Mar2023 | ₹27 Cr | -78.25 | |
Mar2022 | ₹125 Cr | Positive | |
Mar2021 | ₹-19 Cr | Negative | |
Mar2020 | ₹-23 Cr | - |
Compare Cash Flow from Financing Activities of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹5,019.6 Cr | 3.3% | -3.1% | 85.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹121,439.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,076.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,066.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | 3.3% |
-3.1% |
85.2% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses